A radiation-induced gene expression signature as a tool to predict acute radiotherapy-induced adverse side effects

Cancer Letters

Volumn 302, Issue 1, 2011, Pages 20-28

  Mayer, Claudia ^a   Popanda, Odilia ^a   Greve, Burkhard ^b   Fritz, Eberhard ^c,d   Illig, Thomas ^e   Eckardt Schupp, Friederike ^e   Gomolka, Maria ^f   Benner, Axel ^a   Schmezer, Peter ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c FRITZ LIPMANN INSTITUTE   (Germany)

^d MAX PLANCK INSTITUTE FOR BIOGEOCHEMISTRY   (Germany)

^e INSTITUTE OF EPIDEMIOLOGY   (Germany)

^f BUNDESAMT FÜR STRAHLENSCHUTZ   (Germany)

Author keywords

Epstein Barr virus; Ionizing irradiation; MRNA expression; White blood cell subtypes

Indexed keywords

PROTEIN P53;

ADULT; AGED; APOPTOSIS; ARTICLE; B LYMPHOCYTE; BREAST CANCER; CANCER RADIOTHERAPY; CELL CYCLE REGULATION; CLINICAL ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FEMALE; GENE EXPRESSION; GENE FUNCTION; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; IRRADIATION; LYMPHOCYTE; LYMPHOCYTE SUBPOPULATION; LYMPHOCYTE TRANSFORMATION; MALE; PRIORITY JOURNAL; RADIATION INJURY; RADIATION RESPONSE; RADIOSENSITIVITY; SIGNAL TRANSDUCTION;

AGED; BREAST NEOPLASMS; CELL LINE, TRANSFORMED; CELLS, CULTURED; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHOCYTES; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

HUMAN HERPESVIRUS 4;

EID: 79251597054     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2010.12.006     Document Type: Article

References (37)

1. Barnett G.C., West C.M., Dunning A.M., Elliott R.M., Coles C.E., Pharoah P.D., Burnet N.G. Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype. Nat. Rev. Cancer 2009, 9:134-142.
2. Turesson I., Nyman J., Holmberg E., Oden A. Prognostic factors for acute and late skin reactions in radiotherapy patients. Int. J. Radiat. Oncol. Biol. Phys. 1996, 36:1065-1075.
3. Pollard J.M., Gatti R.A. Clinical radiation sensitivity with DNA repair disorders: an overview. Int. J. Radiat. Oncol. Biol. Phys. 2009, 74:1323-1331.
4. Andreassen C.N. Can risk of radiotherapy-induced normal tissue complications be predicted from genetic profiles?. Acta Oncol. 2005, 44:801-815.
5. Rodningen O.K., Overgaard J., Alsner J., Hastie T., Borresen-Dale A.L. Microarray analysis of the transcriptional response to single or multiple doses of ionizing radiation in human subcutaneous fibroblasts. Radiother. Oncol. 2005, 77:231-240.
6. Dikomey E., Borgmann K., Brammer I., Kasten-Pisula U. Molecular mechanisms of individual radiosensitivity studied in normal diploid human fibroblasts. Toxicology 2003, 193:125-135.
7. Hummerich J., Werle-Schneider G., Popanda O., Celebi O., Chang-Claude J., Kropp S., Mayer C., Debus J., Bartsch H., Schmezer P. Constitutive mRNA expression of DNA repair-related genes as a biomarker for clinical radio-resistance: a pilot study in prostate cancer patients receiving radiotherapy. Int J. Radiat. Biol. 2006, 82:593-604.
8. Quarmby S., West C., Magee B., Stewart A., Hunter R., Kumar S. Differential expression of cytokine genes in fibroblasts derived from skin biopsies of patients who developed minimal or severe normal tissue damage after radiotherapy. Radiat. Res. 2002, 157:243-248.
9. Rieger K.E., Hong W.J., Tusher V.G., Tang J., Tibshirani R., Chu G. Toxicity from radiation therapy associated with abnormal transcriptional responses to DNA damage. Proc. Natl. Acad. Sci. USA 2004, 101:6635-6640.
10. Sonis S., Haddad R., Posner M., Watkins B., Fey E., Morgan T.V., Mookanamparambil L., Ramoni M. Gene expression changes in peripheral blood cells provide insight into the biological mechanisms associated with regimen-related toxicities in patients being treated for head and neck cancers. Oral Oncol. 2007, 43:289-300.
11. Svensson J.P., Stalpers L.J., Esveldt-van Lange R.E., Franken N.A., Haveman J., Klein B., Turesson I., Vrieling H., Giphart-Gassler M. Analysis of gene expression using gene sets discriminates cancer patients with and without late radiation toxicity. PLoS Med. 2006, 3:e422.
12. Kruse J.J., Stewart F.A. Gene expression arrays as a tool to unravel mechanisms of normal tissue radiation injury and prediction of response. World J. Gastroenterol. 2007, 13:2669-2674.
13. Neitzel H. A routine method for the establishment of permanent growing lymphoblastoid cell lines. Hum. Genet. 1986, 73:320-326.
14. Foray N., Randrianarison V., Marot D., Perricaudet M., Lenoir G., Feunteun J. Gamma-rays-induced death of human cells carrying mutations of BRCA1 or BRCA2. Oncogene 1999, 18:7334-7342.
15. Greve B., Dreffke K., Rickinger A., Konemann S., Fritz E., Eckardt-Schupp F., Amler S., Sauerland C., Braselmann H., Sauter W., Illig T., Schmezer P., Gomolka M., Willich N., Bolling T. Multicentric investigation of ionising radiation-induced cell death as a predictive parameter of individual radiosensitivity. Apoptosis 2009, 14:226-235.
16. LENT SOMA scales for all anatomic sites. Int. J. Radiat. Oncol. Biol. Phys. 1995, 31:1049-1091.
17. Cox J.D., Stetz J., Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int. J. Radiat. Oncol. Biol. Phys. 1995, 31:1341-1346.
18. Kuhn K., Baker S.C., Chudin E., Lieu M.H., Oeser S., Bennett H., Rigault P., Barker D., McDaniel T.K., Chee M.S. A novel, high-performance random array platform for quantitative gene expression profiling. Genome Res. 2004, 14:2347-2356.
19. Eberwine J., Spencer C., Miyashiro K., Mackler S., Finnell R. Complementary DNA synthesis in situ: methods and applications. Methods Enzymol. 1992, 216:80-100.
20. Westfall P.H., Young S.S. Resampling-based Multiple Testing: Examples and Methods for p-value Adjustment 1993, John Wiley & Sons.
21. Smyth G.K. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 2004, 3:3.
22. Benjamini Y., Drai D., Elmer G., Kafkafi N., Golani I. Controlling the false discovery rate in behavior genetics research. Behav. Brain Res. 2001, 125:279-284.
23. Wiebalk K., Schmezer P., Kropp S., Chang-Claude J., Celebi O., Debus J., Bartsch H., Popanda O. In vitro radiation-induced expression of XPC mRNA as a possible biomarker for developing adverse reactions during radiotherapy. Int. J. Cancer 2007, 121:2340-2345.
24. Gruel G., Voisin P., Vaurijoux A., Roch-Lefevre S., Gregoire E., Maltere P., Petat C., Gidrol X., Roy L. Broad modulation of gene expression in CD4+ lymphocyte subpopulations in response to low doses of ionizing radiation. Radiat. Res. 2008, 170:335-344.
25. Mori M., Benotmane M.A., Tirone I., Hooghe-Peters E.L., Desaintes C. Transcriptional response to ionizing radiation in lymphocyte subsets. Cell Mol. Life Sci. 2005, 62:1489-1501.
26. Wilkins R.C., Wilkinson D., Maharaj H.P., Bellier P.V., Cybulski M.B., McLean J.R. Differential apoptotic response to ionizing radiation in subpopulations of human white blood cells. Mutat. Res. 2002, 513:27-36.
27. Mori M., Benotmane M.A., Vanhove D., van Hummelen P., Hooghe-Peters E.L., Desaintes C. Effect of ionizing radiation on gene expression in CD4+ T lymphocytes and in Jurkat cells: unraveling novel pathways in radiation response. Cell Mol. Life Sci. 2004, 61:1955-1964.
28. Sugimoto M., Tahara H., Ide T., Furuichi Y. Steps involved in immortalization and tumorigenesis in human B-lymphoblastoid cell lines transformed by Epstein-Barr virus. Cancer Res. 2004, 64:3361-3364.
29. Cohen J.I. Epstein-Barr virus infection. N. Engl. J. Med. 2000, 343:481-492.
30. Henderson S., Huen D., Rowe M., Dawson C., Johnson G., Rickinson A. Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death. Proc. Natl. Acad. Sci. USA 1993, 90:8479-8483.
31. Satoh M., Yasuda T., Higaki T., Goto M., Tanuma S., Ide T., Furuichi Y., Sugimoto M. Innate apoptosis of human B lymphoblasts transformed by Epstein-Barr virus: modulation by cellular immortalization and senescence. Cell Struct. Funct. 2003, 28:61-70.
32. Takahashi T., Kawabe T., Okazaki Y., Itoh C., Noda K., Tajima M., Satoh M., Goto M., Mitsui Y., Tahara H., Ide T., Furuichi Y., Sugimoto M. In vitro establishment of tumorigenic human B-lymphoblastoid cell lines transformed by Epstein-Barr virus. DNA Cell Biol. 2003, 22:727-735.
33. Okubo M., Tsurukubo Y., Higaki T., Kawabe T., Goto M., Murase T., Ide T., Furuichi Y., Sugimoto M. Clonal chromosomal aberrations accompanied by strong telomerase activity in immortalization of human B-lymphoblastoid cell lines transformed by Epstein-Barr virus. Cancer Genet. Cytogenet. 2001, 129:30-34.
34. Okada M., Goto M., Furuichi Y., Sugimoto M. Differential effects of cytotoxic drugs on mortal and immortalized B-lymphoblastoid cell lines from normal and Werner's syndrome patients. Biol. Pharm. Bull. 1998, 21:235-239.
35. Paul S., Amundson S.A. Development of gene expression signatures for practical radiation biodosimetry. Int. J. Radiat. Oncol. Biol. Phys. 2008, 71:1236-1244.
36. Henriquez Hernandez L.A., Lara P.C., Pinar B., Bordon E., Rodriguez Gallego C., Bilbao C., Fernandez Perez L., Flores Morales A. Constitutive gene expression profile segregates toxicity in locally advanced breast cancer patients treated with high-dose hyperfractionated radical radiotherapy. Radiat. Oncol. 2009, 4:17.
37. Gervaz P., Morel P., Vozenin-Brotons M.C. Molecular aspects of intestinal radiation-induced fibrosis. Curr. Mol. Med. 2009, 9:273-280.